Related Experiment Video
Updated: Jun 10, 2025
Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Immunohistochemistry Study of Antimicrobial Peptides as a Future Diagnostic and Prognostic Tool for Periprosthetic
Emanuel-Cristian Sandu1,2, Bogdan Serban1,2, Sergiu Iordache2
1Orthopedics and Traumatology, "Carol Davila" Faculty of Medicine, Bucharest, ROU.
Abstract:
Periprosthetic joint infection (PJI) is a reputable complication of arthroplasty surgery. Septic loosening is an implant biofilm-related infection with different characteristics and treatment than aseptic loosening. Misdiagnosing PJI results in choosing an inappropriate treatment and, in most cases, failure to achieve asepsis. The worldwide increase of arthroplasty surgeries forces us to research more accurate ways to detect PJIs earlier, cheaper, and faster. In the current study, we investigated 52 arthroplasty revision surgeries (septic and aseptic) and, using immunohistochemistry staining of periprosthetic tissue, successfully demonstrated an important increase in antimicrobial peptides human β defensin-3 (HBD-3) and cathelicidin (LL-37) in the PJI group. Furthermore, we observed that patients with a positive LL-37 stain were associated with a more reserved prognosis at one-year follow-up. These promising results suggest that antimicrobial peptides HBD-3 and LL-37 could be used as future biomarkers for PJI detection.
Insights
New biomarkers, human β defensin-3 (HBD-3) and cathelicidin (LL-37), show promise for detecting periprosthetic joint infection (PJI) in arthroplasty patients. Elevated levels indicate infection and potentially a poorer prognosis.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Biomarker Discovery
Background:
- Periprosthetic joint infection (PJI) is a serious complication following arthroplasty.
- Accurate and timely diagnosis of PJI is crucial for successful treatment and preventing implant failure.
- Current diagnostic methods for PJI can be time-consuming and may lack sensitivity.
Purpose of the Study:
- To investigate the potential of antimicrobial peptides (AMPs) as biomarkers for PJI detection.
- To evaluate the diagnostic utility of human β defensin-3 (HBD-3) and cathelicidin (LL-37) in periprosthetic tissues.
- To assess the correlation between AMP levels and patient prognosis after revision surgery.
Main Methods:
- Immunohistochemistry staining was performed on periprosthetic tissues from 52 arthroplasty revision surgeries.
- Samples were analyzed for the expression of HBD-3 and LL-37.
- Patients were categorized into septic (PJI) and aseptic loosening groups.
Main Results:
- Significantly increased levels of HBD-3 and LL-37 were observed in the PJI group compared to the aseptic group.
- Positive LL-37 staining was associated with a poorer patient prognosis at one-year follow-up.
- These findings suggest a role for AMPs in PJI pathogenesis and diagnosis.
Conclusions:
- Antimicrobial peptides HBD-3 and LL-37 show potential as novel biomarkers for PJI detection.
- LL-37 may also serve as a prognostic indicator in patients with PJI.
- Further research is warranted to validate these findings and explore their clinical application.
